Current relevance of pharmacogenetics in immunomodulation treatment for Crohn's disease.
about
Clinical and genetic factors predicting response to therapy in patients with Crohn's disease.Personalizing health care: feasibility and future implications.An open-label prospective randomized multicenter study of intensive versus weekly granulocyte and monocyte apheresis in active crohn's diseaseBeyond gene discovery in inflammatory bowel disease: the emerging role of epigenetics.Allopurinol enhanced thiopurine treatment for inflammatory bowel disease: safety considerations and guidelines for use.Update 2014: advances to optimize 6-mercaptopurine and azathioprine to reduce toxicity and improve efficacy in the management of IBD.Predicting outcomes in acute severe ulcerative colitis.Update on thiopurine pharmacogenetics in inflammatory bowel disease.Systematic review: predicting and optimising response to anti-TNF therapy in Crohn's disease - algorithm for practical management.NUDT15, FTO, and RUNX1 genetic variants and thiopurine intolerance among Japanese patients with inflammatory bowel diseases.Monitoring thiopurine metabolites in inflammatory bowel disease.Pharmacogenetics of inflammatory bowel disease.Thiopurine methyltransferase genotype and activity cannot predict outcomes of azathioprine maintenance therapy for antineutrophil cytoplasmic antibody associated vasculitis: A retrospective cohort study.Genetic polymorphism inATG16L1gene influences the response to adalimumab in Crohn's disease patients
P2860
Q33695605-381E35A6-8E0B-4DDC-BA02-6AA24CE71A79Q34938911-363B0D4F-2C6F-4005-84FC-F2031BAF4B2EQ35846531-81F1EE44-02A1-4577-A463-63283328012EQ37572837-52DFF6E0-514E-4070-931F-20E7EC918B03Q38179509-C6D8F6BA-959C-49E6-A73C-54F40FF63F4CQ38253469-D6203338-9515-4A23-946A-6E51C18C86E4Q38286166-5ABE05D9-D282-4A8F-A9C6-A28C6A7A9D5EQ38525578-C38D79F1-8039-4D8D-A688-730F1DAAC81DQ38619950-64D91847-68F8-4351-B410-E877E4A394A6Q41080533-47D743B3-1030-4C7A-8E9A-1BFF1CFFBDEEQ41642129-3F88FB27-5FEA-44E7-A99E-097FDD8D1951Q41673937-7D4E5D9D-5D43-4074-B680-03F5881BDD1DQ55259199-68DAD652-D4F0-4B56-A633-A4414131E626Q58862198-DE8D2103-9303-434E-940A-E031FC42E935
P2860
Current relevance of pharmacogenetics in immunomodulation treatment for Crohn's disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Current relevance of pharmacogenetics in immunomodulation treatment for Crohn's disease.
@en
type
label
Current relevance of pharmacogenetics in immunomodulation treatment for Crohn's disease.
@en
prefLabel
Current relevance of pharmacogenetics in immunomodulation treatment for Crohn's disease.
@en
P2860
P1476
Current relevance of pharmacogenetics in immunomodulation treatment for Crohn's disease.
@en
P2093
Murray L Barclay
Rebecca L Roberts
P2860
P304
P356
10.1111/J.1440-1746.2012.07220.X
P577
2012-10-01T00:00:00Z